Forty‐nine cases of Wilms' tumor treated at the Mallinckrodt Institute of Radiology and Children's Hospital, Washington University Medical Center, between 1950 and December 1969, were retrospectively analyzed. The most important prognostic factors were the anatomical stage of the tumor and some pathologic findings such as invasion of the renal capsule, the renal vein or inferior vena cava, and metastases to the regional lymph nodes or to other organs. A histopathologic classification based on differentiation of the tumor is presented and correlated with cure rates. Stage I lesions had a very good prognosis (85% 3‐year survival NED), even without high‐dose irradiation or prolonged chemotherapy. Triple therapy, involving nephrectomy, irradiation, and prolonged chemotherapy yielded a 55% survival rate in patients with Stage II and 30% in Stage IV (patients with pulmonary metastases). Stage III tumors showed an unsatisfactory response to this comprehensive approach. Patients with bilateral tumors are potentially curable if aggresively treated. From this study it can be concluded that: 1. thorough analysis of the clinical and pathologic characteristics of the tumor should be made in every case and management should be individualized, to avoid excessive treatment in early lesions with favorable prognosis, and 2. carefully administered postoperative irradiation and prolonged chemotherapy may improve the poor results in extensive lesions, even in the presence of distant metastases, with relatively minor sequelae in the surviving children. The late effects of vigorous and prolonged chemotherapy on the bone marrow, the immunologic surveillance system, and the germinal cells of the gonads as well as the repercussion on normal growth of these children remain to be evaluated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.